These granulomatous disorders can occur in many conditions in cancer patients (i.e., related to opportunistic infections associated with cancer, systemic granulomatosis due to cancer treatment, especially checkpoint inhibitors or BRAF/MEK inhibitors) [9]. Here, BRAF is linked to cancer.